Key result
PASMC Piezo1 drives hypoxia-induced pulmonary hypertension via vascular remodeling and capillary rarefaction.
Why the study?
The specific role of Piezo1 in pulmonary arterial smooth muscle cells for pulmonary hypertension development and progression was unclear.
Does smooth muscle cell-specific Piezo1 knockout prevent hypoxia-induced pulmonary hypertension development in mice?
Does smooth muscle cell-specific Piezo1 knockout prevent hypoxia-induced pulmonary hypertension development in mice?
Piezo1 in pulmonary arterial smooth muscle cells plays a critical role in the pathogenesis of pulmonary hypertension, suggesting it may be a potential therapeutic target.
BACKGROUND: Pulmonary hypertension (PH) is a life-threatening and progressive yet incurable disease. The hallmarks of PH comprise (1) sustained contraction and (2) excessive proliferation of pulmonary arterial smooth muscle cells (PASMCs). A major stimulus to which PASMCs are exposed during PH development is altered mechanical stress, originating from increased blood pressure, changes in blood flow velocity, and a progressive stiffening of pulmonary arteries. Mechanosensitive ion channels, including Piezo1 (Piezo-type mechanosensitive ion channel component-1), perceive such mechanical stimuli and translate them into a variety of cellular responses, including contractility or proliferation. Thus, the objective of the present study was to elucidate the specific role of Piezo1 in PASMCs for PH development and progression. METHODS: The cell-type specific function of Piezo1 in PH was assessed in (1) PASMCs and lung tissues from patients with PH and (2) 2 mouse strains characterized by smooth muscle cell–specific, conditional Piezo1 knockout. Taking advantage of these strains, the smooth muscle cell–specific role of Piezo1 in PH development and progression was assessed in isolated, perfused, and ventilated mouse lungs, wire myography, and proliferation assays. Finally, in vivo function of smooth muscle cell–specific Piezo1 knockout was evaluated upon induction of chronic hypoxia–induced PH in these mice with insights into pulmonary vascular cell senescence. RESULTS: Compared with healthy controls, PASMCs from patients with PH featured an elevated Piezo1 expression and increased proliferative phenotype. Smooth muscle cell–specific Piezo1 deletion, as confirmed via quantitative real-time polymerase chain reaction and patch clamp recordings, prevented the hypoxia-induced increase in PASMC proliferation in mice. Moreover, Piezo1 knockout reduced hypoxic pulmonary vasoconstriction in isolated, perfused, and ventilated mouse lungs, endothelial-denuded pulmonary arteries, and hemodynamic measurements in vivo. Consequently, Piezo1 -deficient mice were considerably protected against chronic hypoxia–induced PH development with ameliorated right heart hypertrophy and improved hemodynamic function. In addition, distal pulmonary capillaries were preserved in the Piezo1-knockout mice, associated with a lower number of senescent endothelial cells. CONCLUSIONS: This study provides evidence that Piezo1 expressed in PASMCs is critically involved in the pathogenesis of PH by controlling pulmonary vascular tone, arterial remodeling, and associated lung capillary rarefaction due to endothelial cell senescence.
No takes yet. Share an insight, caveat, or question.
Knoepp et al. (2025) studied Pulmonary hypertension. Smooth muscle cell-specific Piezo1 knockout vs. Healthy controls / wild-type mice was evaluated on Hypoxia-induced PASMC proliferation and PH development. Smooth muscle cell-specific Piezo1 deletion prevented hypoxia-induced PASMC proliferation and protected mice against chronic hypoxia-induced pulmonary hypertension development.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: